CasLoc logo
All Cases PTAB Litigations UPC Oppositions

OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC.

1:14-cv-04508

Overview

Case Number 1:14-cv-04508
Filing Date 2014-07-11
Status Terminated
Termination Date 2018-03-05
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Counter Claimant

MYLAN LABORATORIES LIMITED NPE (University / Research)

Represented By

6 Attorneys Listed

JOHN F. BRENNER

PEPPER HAMILTON , LLP

Tel: +1 (609) 951-4193
Fax: +1 (609) 452-1147

301 CARNEGIE CENTER, SUITE 400

BRIAN RONALD ZURICH

PEPPER HAMILTON LLP

Tel: +1 (609) 951-4159

301 CARNEGIE CENTER, SUITE 400

JEFFREY S. SOOS

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

ARNOLD B. CALMANN

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

KATHERINE ANN ESCANLAR

SAIBER LLC

Tel: +1 (973) 622-3333

SAIBER LLC, ONE GATEWAY CENTER

JOHN MICHAEL VAZQUEZ

CRITCHLEY, KINUM & VAZQUEZ LLC

Tel: +1 (973) 422-9200

CRITCHLEY, KINUM & VAZQUEZ LLC, 75 LIVINGSTON AVE.

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8759350
Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
Filed: 2003-12-25
Issued: 2014-06-24
Active (0.5 yrs remaining) +1256d PTA
Expires: 2027-06-03
US7853092
Feature block compression/decompression
Filed: 2007-01-11
Issued: 2010-12-14
Active (2.9 yrs remaining) +1008d PTA
Expires: 2029-10-15
US8642760
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Filed: 2011-06-23
Issued: 2014-02-04
Active (4.6 yrs remaining)
Expires: 2031-06-23
US8017615
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Filed: 2007-04-26
Issued: 2011-09-13
Expired (Term Ended)
Expires: 2024-06-16
US8580796
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Filed: 2012-01-13
Issued: 2013-11-12
Active (5.1 yrs remaining)
Expires: 2032-01-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1256 days) / Cellect Scrutiny β€” Over 1256 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

73

Dispositive

32

Granted

27

Denied

0

Pending / Review

43

Motions by Category

Motion to Dismiss 10 Procedural / Extension Motion 27 Motion for Preliminary Injunction / TRO 7 Claim Construction / Markman Filing 7 Motion to Strike / Sanctions 7 Motion for Summary Judgment (Infringement) 7 Motion for Summary Judgment (Invalidity) 5 Motion for Summary Judgment (Rule 56) 3

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Invalidity) Pending / Under Review
ORDER dismissing as moot Defendant Mylan's 208 Motion to join Defendant Apotex's motion for summary judgment of invalidity. Signed by Judge Jerome B. Simandle o...
Entry #290 • 2017-09-29 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
FILED UNDER SEAL ORDER dismissing without prejudice Defendant Mylan's 205 Motion for Summary Judgment ; granting Otsuka's Rule 56(d) 232 Motion, etc. Signed by ...
Entry #291 • 2017-09-29 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Minute Entry for proceedings held before Chief Judge Jerome B. Simandle: Motion Hearing held on 10/24/2016 re 205, 208 MOTION for Summary Judgment. Ordered Deci...
Entry #256 • 2016-10-24 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REPLY to Response to Motion filed by MYLAN INC., MYLAN PHARMACEUTICALS INC. re 205 MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,642,760;...
Entry #244 • 2016-10-11 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
REPLY to Response to Motion filed by MYLAN INC., MYLAN PHARMACEUTICALS INC. re 208 MOTION for Summary Judgment of Invalidity of U.S. Patent No. 8,017,615 (Joini...
Entry #247 • 2016-10-11 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
NOTICE by OTSUKA PHARMACEUTICAL CO., LTD. re 208 MOTION for Summary Judgment of Invalidity of U.S. Patent No. 8,017,615 (Joining Apotex's Motion -- see ECF Nos....
Entry #231 • 2016-10-03 Document →

Docket Entries

(318 total)
Pleading / Complaint

COMPLAINT against MYLAN INC., MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-5803671), filed by OTSUKA PHARMACEUTICAL CO., LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Certification A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(bdk, ) (Entered: 07/17/2014)

Entry #1 • 2014-07-11
1
Pleading / Complaint

COMPLAINT against MYLAN INC., MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-5803671), filed by OTSUKA PHARMACEUTICAL CO., LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Certification A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(bdk, ) (Entered: 07/17/2014)

Entry #1 • 2014-07-11
2
Pleading / Complaint

COMPLAINT against MYLAN INC., MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-5803671), filed by OTSUKA PHARMACEUTICAL CO., LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Certification A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(bdk, ) (Entered: 07/17/2014)

Entry #1 • 2014-07-11
2
Pleading / Complaint

COMPLAINT against MYLAN INC., MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-5803671), filed by OTSUKA PHARMACEUTICAL CO., LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Certification A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(bdk, ) (Entered: 07/17/2014)

Entry #1 • 2014-07-11
2
Pleading / Complaint

COMPLAINT against MYLAN INC., MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-5803671), filed by OTSUKA PHARMACEUTICAL CO., LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Certification A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(bdk, ) (Entered: 07/17/2014)

Entry #1 • 2014-07-11
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc